SyntheX

Approved

San Diego, United StatesFounded 2020synthexlabs.com

SyntheX is expanding the frontier of drug discovery with target-centric cell-based functional selection.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $27.5M

SyntheX is expanding the frontier of drug discovery with target-centric cell-based functional selection.

Small Molecules

Total raised:$27.5M

Series A$23MKhosla VenturesOct 15, 2022

Seed$4.5MUndisclosedJun 15, 2021